TIBCO Software Inc., together with INTEGROMICS, a provider of software solutions for data management and data analysis in genomics, proteomics and drug discovery, announced a solution for genomics research that provides researchers and scientists with a direct, interactive, visual approach to data analysis that rapidly reveals insights and unexpected relationships in genomics data.
TIBCO SPOTFIRE AND INTEGROMICS ANNOUNCE GENOMICS DATA ANALYSIS SOLUTION TO RADICALLY SPEED DRUG RESEARCH AND DEVELOPMENT
Spotfire Platform Evolves with INTEGROMICS to Lead the Industry in Advancing Life Sciences Research, Discovery and Development
SOMERVILLE, Mass., – September 24, 2008 –TIBCO Software Inc. (NASDAQ: TIBX), together with INTEGROMICS, a provider of state-of-the-art software solutions for data management and data analysis in genomics, proteomics and drug discovery, today announced a solution for genomics research that provides researchers and scientists with a direct, interactive, visual approach to data analysis that rapidly reveals insights and unexpected relationships in genomics data.
Genomics technologies - used by pharmaceutical R&D departments to understand disease biology and drug response in order to develop new and better drugs -- are now used across the entire drug development process to better understand disease biology, mechanisms of drug action, mechanisms of toxicity, and individuals and their response to a drug. Genomics-based biomarkers are dramatically impacting drug development by providing more precise diagnoses of disease states and drug response in individual patients. The software used to analyze and explore genomic data had not kept pace with the advancing genomics research. Spotfire and INTEGROMICS, however, joined forces to address the needs of modern genomics research in areas including biomarker research, translational medicine, and systems biology by introducing INTEGROMICS Biomarker Discovery for TIBCO Spotfire®.
The scientific and workflow knowledge of INTEGROMICS, combined with the adaptability and ease of use of the TIBCO Spotfire platform, provide researchers with a powerful genomic data analysis environment. The new solution enables pharmaceutical, biotechnology, and academic research groups to quickly find and categorize complex patterns. With interactive analysis and high-impact visualization capabilities, researchers and scientists can examine the expression and annotation dimensions of their data and perform a variety of numerical analyses. Pharmaceutical companies can also use Spotfire® as a flexible analytics platform to allow them to combine and analyze new types of data in order to more quickly pursue their hypotheses and research strategies.
“Having developed microarray analytics for the last five years, we are confident that this combined solution will provide researchers with a powerful environment to accelerate discovery and provide accurate, up-to-date analytics from a single reliable source,” said Alberto Pasqual, vice president of R & D, INTEGROMICS. “With this set of tools, life science researchers can ask and answer new questions and create an advanced problem solving environment.”
“Genomics research typically involves measuring the activity of thousands of genes in many different treatments or conditions and combining that information with other information about the genes to uncover information about the biology of disease and treatment,” said Christian Marcazzo, senior director of Life Science Analytics for TIBCO Spotfire. “This solution helps researchers and scientists address one of the industry’s long standing challenges of creating knowledge from mass data by easily integrating multiple data sources and transforming data into an interactive decision-making asset.”
INTEGROMICS, S.L. provides IT solutions for Life Sciences (Genomics and Proteomics). In the post-genomic era, Integromics S.L. offers state-of-the-art products, services and training in two strategic areas: data management/integration and intelligent data analysis. The company has developed a network of collaborations both in industry and academia to provide complete technological solutions that will help our clients to achieve their goals. Integromics S.L., was founded in 2002 and is based in Granada, Spain, with offices in Madrid (Spain) and Philadelphia (USA). Integromics Inc. is a wholly owned subsidiary which was established in 2007. For more information, visit http://www.integromics.com/
TIBCO Software Inc. is a leading provider of enterprise analytics software for next generation business intelligence. TIBCO Spotfire products offer a visual and interactive experience that helps professionals quickly discover new and actionable insights in information. Distinguished by its speed to insight and adaptability to specific business challenges, Spotfire rapidly reveals unseen threats and new opportunities, creating significant economic value. Spotfire customers include industry leaders among the Global 2000 that have deployed Spotfire analytics to gain an information advantage over their competitors. For more information, visit http://spotfire.tibco.com